AbbVie (Mexico) Today
ABBV Stock | MXN 3,503 63.41 1.78% |
Performance0 of 100
| Odds Of DistressLess than 10
|
AbbVie is trading at 3503.00 as of the 20th of January 2025; that is 1.78 percent decrease since the beginning of the trading day. The stock's open price was 3566.41. AbbVie has less than a 10 % chance of experiencing some financial distress in the next two years of operation, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 21st of December 2024 and ending today, the 20th of January 2025. Click here to learn more.
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company was incorporated in 2012 and is based in North Chicago, Illinois. ABBVIE INC operates under Drug ManufacturersGeneral classification in Mexico and is traded on Mexico Stock Exchange. The company has 1.77 B outstanding shares. More on AbbVie Inc
Moving against AbbVie Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
AbbVie Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. AbbVie's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding AbbVie or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Chairman | Richard Gonzalez |
Business Concentration | Drug Manufacturers—General, Healthcare (View all Sectors) |
AbbVie Inc (ABBV) is traded on Mexican Exchange in Mexico and employs 29 people. The company currently falls under 'Mega-Cap' category with a current market capitalization of 5.06 T. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate AbbVie's market, we take the total number of its shares issued and multiply it by AbbVie's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. AbbVie Inc operates under Healthcare sector and is part of Drug Manufacturers—General industry. The entity has 1.77 B outstanding shares.
AbbVie Inc has accumulated about 8.6 B in cash with 22.78 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.87.
Check AbbVie Probability Of Bankruptcy
Ownership AllocationAbbVie holds a total of 1.77 Billion outstanding shares. The majority of AbbVie Inc outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in AbbVie Inc to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in AbbVie. Please pay attention to any change in the institutional holdings of AbbVie Inc as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check AbbVie Ownership Details
AbbVie Inc Risk Profiles
Although AbbVie's alpha and beta are two of the key measurements used to evaluate AbbVie's performance over the market, the standard measures of volatility play an important role as well.
Mean Deviation | 1.14 | |||
Standard Deviation | 2.37 | |||
Variance | 5.63 | |||
Risk Adjusted Performance | (0.01) |
AbbVie Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in AbbVie without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Center Now
Portfolio CenterAll portfolio management and optimization tools to improve performance of your portfolios |
All Next | Launch Module |
AbbVie Corporate Directors
Brett Hart | Independent Director | Profile | |
Roxanne Austin | Independent Director | Profile | |
Edward Rapp | Independent Director | Profile | |
Frederick Waddell | Independent Director | Profile |
Additional Tools for AbbVie Stock Analysis
When running AbbVie's price analysis, check to measure AbbVie's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AbbVie is operating at the current time. Most of AbbVie's value examination focuses on studying past and present price action to predict the probability of AbbVie's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AbbVie's price. Additionally, you may evaluate how the addition of AbbVie to your portfolios can decrease your overall portfolio volatility.